Next Article in Journal
Biallelic Loss-of-Function Variants in BICD1 Are Associated with Peripheral Neuropathy and Hearing Loss
Previous Article in Journal
Preliminary Study on Expression and Function of the Chicken W Chromosome Gene MIER3 in Embryonic Gonads
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 10
10.3390/ijms24108898
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Design, Synthesis, In Vitro Antifungal Activity and Mechanism Study of the Novel 4-Substituted Mandelic Acid Derivatives

by
Biao Chen
1,
Dandan Song
2,
Huabin Shi
2,
Kuai Chen
2,
Zhibing Wu
2,* and
Huifang Chai
1,*
1
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
2
State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang 550025, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(10), 8898; https://doi.org/10.3390/ijms24108898
Submission received: 14 April 2023 / Revised: 12 May 2023 / Accepted: 15 May 2023 / Published: 17 May 2023
(This article belongs to the Section Molecular Toxicology)
Browse Figures
Review Reports Versions Notes

Abstract

:
Plant diseases caused by phytopathogenic fungi are a serious threat in the process of crop production and cause large economic losses to global agriculture. To obtain high-antifungal-activity compounds with novel action mechanisms, a series of 4-substituted mandelic acid derivatives containing a 1,3,4-oxadiazole moiety were designed and synthesized. In vitro bioassay results revealed that some compounds exhibited excellent activity against the tested fungi. Among them, the EC50 values of E13 against Gibberella saubinetii (G. saubinetii), E6 against Verticillium dahlia (V. dahlia), and E18 against Sclerotinia sclerotiorum (S. sclerotiorum) were 20.4, 12.7, and 8.0 mg/L, respectively, which were highly superior to that of the commercialized fungicide mandipropamid. The morphological studies of G. saubinetii with a fluorescence microscope (FM) and scanning electron microscope (SEM) indicated that E13 broke the surface of the hyphae and destroyed cell membrane integrity with increased concentration, thereby inhibiting fungal reproduction. Further cytoplasmic content leakage determination results showed a dramatic increase of the nucleic acid and protein concentrations in mycelia with E13 treatment, which also indicated that the title compound E13 could destroy cell membrane integrity and affect the growth of fungi. These results provide important information for further study of the mechanism of action of mandelic acid derivatives and their structural derivatization.

1. Introduction

Plant diseases caused by phytopathogenic fungi are a serious threat to the process of crop production and cause large economic losses to global agriculture [1,2]. More than 8000 species of fungi are known to cause plant diseases, such as Fusarium graminearum (F. graminearum), Gibberella saubinetii (G. saubinetii), Sclerotinia sclerotiorum (S. sclerotiorum), Botrytis cinerea (B. cinerea), etc., and these fungi cause 85% of plant diseases and have caused huge economic crop losses [3]. Moreover, some fungi can also produce toxins that are harmful to animal and human health, such as aflatoxins, fumonisins, and trichocenes, which will last for many years [4,5]. Therefore, the prevention and control of fungal diseases have become an urgent problem in agricultural production. Currently, chemical control is still an effective method to prevent plant fungal diseases. However, the frequent use and abuse of chemical pesticides not only bring about environmental pollution and pesticide residue problems but also accelerate the emergence of resistance in pathogenic fungi [6,7]. At present, it is urgent to develop new antifungal pesticides with high efficiency, novel action mechanism, no cross-resistance, and environmental friendliness [8].
Mandelic acid (MA) has very specific physiological activity and is used as an important intermediate to synthesize medicines, such as cephalosporin antibiotics, vasodilators such as ring mandelic acid, nonsteroidal anti-inflammatory drugs such as norrecoxib and celecoxib, and urinary tract disinfectants such as urotropine [9,10,11]. In terms of pesticides, mandipropamid was the first commercialized mandelic acid fungicide, marketed in 2001, and had a good control effect on Pseudoperonospora cubensis and Pphytophora nicotianae [12,13]. As reported in recent years, 1,3,4-oxadiazole derivatives exhibit a wide range of excellent pesticide activities, including antibacterial [14,15,16], antifungal [17], anti-TMV [18,19,20], and nematicidal activities (Figure 1) [21], and therefore is widely considered in pesticide design.
To obtain high antifungal activity compounds with a novel action mechanism, a series of 4-substituted mandelic acid derivatives containing a “1,3,4-oxadiazole thioether” were designed and synthesized (Figure 2). In vitro antifngal bioassays indicated that some compounds exhibited excellent antifungal activities against three tested fungi (G. saubinetii, V. dahlia, and S. sclerotiorum). In order to investigate the antifungal mechanism of the highly active compounds, we conducted morphological studies using the compound E13. The morphological study of G. saubinetii hyphae with the treatment of title compound E13 by FM and SEM revealed that it could remarkably break the surface morphology of mycelia. Furthermore, the results of intracellular nucleic acid and protein leakage experiments further demonstrated that title compound E13 could destroy the integrity of the cell membrane of G. saubinetii, thus inhibiting the growth of mycelium. These results provide important clues for the further mechanism study and derivatization of mandelic acid derivatives used for plant disease control.

2. Results and Discussion

2.1. Chemistry

The synthetic route is depicted in Figure 3. As initial materials, 4-substituted mandelic acids were used to synthesize key intermediate ester B. Then, C was obtained from B through hydrazinolysis in the presence of 80% hydrazine hydrate and reacted with CS2 under base conditions to form intermediate thiol D. Title compounds E1–E28 were synthesized from D with different substituted benzyl halides with K2CO3 in cetonitrile and water. The title compounds were characterized by 1H nuclear magnetic resonance (NMR), 13C NMR, 19F NMR spectroscopy, and high-resolution mass spectrometry (HRMS).

2.2. Crystal Structure

The crystal structure of title compound E9 was confirmed by X-ray single-crystal diffraction analysis (Figure 4). A combination of absorption correction and Lorentz polarization was adopted. Structural solutions and F2-based full-matrix least-squares refinements were conducted using SHELXT-14 software. An isotropic refinement of the nonhydrogen atoms was then carried out. Subsequently, the scattering factors of the neutral atoms were analyzed by incorporating an anomalous dispersion correction. The majority of H2O molecules in the crystalline structure were removed using the SQUEEZE option in PLATON.

2.3. In Vitro Antifungal Activity Analysis

The preliminary antifungal activity results of the title compounds against seven plant phytogenic fungi at 100 mg/L are shown in Table 1. As indicated, some title compounds exhibited excellent inhibitory activities against the seven tested fungi at a concentration of 100 mg/L. In detail, compounds E10, E13, and E14 showed good antifungal activity against G. saubinetii, with inhibition rates of 78.5%, 78.3%, and 80.2%, respectively, which were higher than mandipropamid (19.1%). The inhibition rates of E6, E10, E13, E14, and E20 against V. dahliae were 93.8%, 91.8%, 100%, 95.9%, and 94.4%, respectively, which were much higher than mandipropamid (27.2%). Compounds E9, E13, and E17 exhibited 92.8%, 92.5%, and 89.7% inhibition of S. sclerotiorum, respectively, which was much better than that of the commercialized fungicide mandipropamid (14.0%). Compounds E10, E13, and E14 showed good antifungal activity against Fusarium oxysporum, with inhibition rates of 69.4%, 70.3%, and 68.8%, respectively, which were higher than mandipropamid (26.5%). Compounds E5, E7, E10, and E13 showed remarkable antifungal activity against T. cucumeris, with inhibition rates of 84.9%, 81.4%, 81.1%, and 87.5%, respectively, which were higher than hymexazol (79.3%). These results indicate the broad-spectrum inhibitory activities of 4-substituted mandelic acid derivatives. As shown in Table 2, some title compounds showed obviously superior antifungal activity than commercial pesticides. For example, the EC50 values of E13, E14, and E17 against G. saubinetii were 20.4, 21.5, and 22.0 mg/L, respectively; the EC50 values of E6, E13, and E18 against V. dahlia were 12.7, 18.5, and 15.7 mg/L, respectively; the EC50 values of E8, E9, and E18 against S. sclerotiorum were 13.8, 10.3, and 8.0 mg/L, respectively; the EC50 values of E7 and E13 against T. cucumeris were 5.7 and 7.1 mg/L, respectively; which were much higher than corresponding control fungicides. The preliminary structure-activity relationship analysis showed that when R2 were the same substituted phenyl groups and R1 were electron-withdrawing groups, the anti-G. saubinetii and anti-S. sclerotiorum activities were higher than electron-donating groups, such as E9 > E2, E13/E20 > E6, E14/E21 > E7. When R1 was the same group and R2 was substituted phenyl groups, the anti-G. saubinetii and anti-S. sclerotiorum activities were higher than that of non-substituted phenyl groups, such as E2/E7 > E1, E9/E10/E13/E14 > E8. In addition, when R1 is a halogen group and the para-substituent group or ortho-substituted group of R2 are halogen groups, the anti-G. saubinetii and anti-S. sclerotiorum activities were higher than electron-donating groups, such as E13/E14 > E9, E24/E25 > E22.

2.4. Morphological Study of G. saubinetii Fungus with SEM

To investigate the antifungal mechanism, we conducted morphological studies using the compound E13. The morphology of G. saubineti treated with title compound E13 was observed by SEM (Figure 5). As shown in Figure 5A, hyphae grew normally with the treatment of 1% DMSO (CK group), and the morphology was relatively complete. When treated with the compound E13 at the concentration of 2 eq. EC50, the surface of the mycelia began to shrink obviously, as shown in the red circle in Figure 5B. With the concentration of E13 increased to 4 eq. EC50, the change in the mycelia morphology intensified, and some holes appeared on the surface of the mycelia, which were marked by red arrows in Figure 5C. When the concentration reached 8 eq. EC50, all the mycelia were contracted, and some surfaces were seriously damaged, as shown in the red circle in Figure 5D. We speculated that compound E13 could destroy the cell membrane and wall of G. saubineti, culminating in the death of hyphae.

2.5. Morphological Study of G. saubinetii Fungus with FM

To further determine whether the membrane of mycelium was damaged, propidium iodide (PI) dye was used to stain the DNA, and fluorescence microscopy (FM) was used to observe its fluorescence. PI can enter the cell across the damaged cellular membrane and specifically bind with DNA to emit red fluorescence [22]. As shown in panels A, B, and C of Figure 6, the cellular membrane of the hyphal cells without staining was colorless. However, when compared with the blank control (Figure 6D), strong fluorescence intensity was observed by FM in the G. saubinetii hyphae treated with E13 at a concentration of 2 eq. and 4 eq. EC50 (Figure 6E,F). Moreover, as shown in Figure 6E,F, the higher the concentration of E13, the more red-colored hyphae appear. Therefore, the FM observation further proved that target compound E13 could destroy the membrane integrity of G. saubinetii, and the effect was dose-dependent.

2.6. Mechanistic Study of the Antifungal Activity of E13

Further cytoplasmic content leakage assay confirmed the membrane of mycelia was damaged. Nucleic acid and protein concentrations in mycelial suspensions can be evaluated by measuring the changes in absorbance at 260 and 280 nm [23]. As shown in Figure 7, compared with the blank control (CK) group, the absorbance values at 260 and 280 nm were significantly increased within 2 h after treatment with 2 eq. and 4 eq. EC50 of compound E13 and stabilized at approximately 8 h. Therefore, it can be inferred that the nucleic acids and proteins of G. saubinetii mycelia were significantly released after treatment with E13, and the effect was dose-dependent. This result was consistent with the morphological observation by SEM and FM experiments. When treated with the title compound E13, the cell membrane integrity was damaged, and the nucleic acids and proteins were released, thereby inhibiting the growth of fungi.

3. Materials and Methods

3.1. Instruments and Chemicals

1H nuclear magnetic resonance (NMR), 13C NMR, and 19F NMR spectra were acquired on a Bruker 400 NMR spectrometer (Bruker Corporation, Karlsruhe, Germany) with tetramethylsilane (TMS) as the internal standard and DMSO-d6 as the solvent. High-resolution mass spectrometry (HRMS) data were obtained on a Thermo Scientific Q Exactive (Thermo Scientific, Waltham, MA, USA). X-ray crystallographic data were collected by a D8 QUEST (Bruker Corporation, Karlsruhe, Germany). The morphology of the fungus was observed by a Nova Nano SEM450 scanning electron microscope (SEM) instrument (Thermo Fisher Scientific, Waltham, MA, USA) and an Olympus-BX53F fluorescence microscope (FM) (Olympus Ltd., Tokyo, Japan). The cytoplasmic content leakage assay was performed by Cytation™5 multimode readers (BioTek Instruments, Inc., Winooski, VT, USA). HPLC analysis was performed on LC–2030C (Shimadzu, Kyoto, Japan). Melting points were measured with SGW X–4B binocular microscope melting point apparatus (Inesa, Shanghai, China). All reagents and solvents are commercially available with chemical or analytical purity. Benzyl halides were purchased from Shanghai Haohong Scientific Co., Ltd. (Shanghai, China).

3.2. Fungi

Gibberella saubinetii (Durieu and Mont.) Sacc., Verticillium dahliae Kleb., Sclerotinia sclerotiorum (Lib.) de Bary, Fusarium oxysporum f. sp. Cucumerinum, Phytophthora capsici Leonian and Thanatephorus cucumeris (A.B. Frank) Donk were purchased from Beijing Beina Chuanglian Biotechnology Institute, China. Fusarium proliferatum (Matsush.) Nirenberg ex Gerlach and Nirenberg was provided by our laboratory (State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Guiyang, China). All these fungi were grown on potato dextrose agar (PDA) plates at 25 ± 1 °C and maintained at 4 °C.

3.3. Crystallographic Analysis

A single crystal of title compound E9 suitable for X-ray diffraction analysis was obtained by slow evaporation of DMF solution at room temperature. Crystallographic data of compound E9: colorless crystal, C17H15FN2O2S, Mr = 330.37, orthorhombic, space group Pbcn, a = 11.2260 (5) Å, b = 17.9952 (8) Å, c = 7.8108 (3) Å; α = 90°, β = 90°, γ = 90°; μ = 2.018 mm−1, V = 1577.89 (12) Å3, Z = 4, Dc = 1.391 g cm−1, F (000) = 688.0, Reflection collected/Independent reflection measured = 2728/2645, Goodness-of-fit on F2 = 1.067, Fine, R1 = 0.0435, wR2 = 0.1112. The crystallographic data of E9 are provided in Table S1 in the Supporting Information. The supplementary data for title compound E9 have been deposited in the Cambridge Crystallographic Data Centre (accessed on 18 September 2020, http://www.ccdc.cam.ac.uk/conts/retrieving.html) under deposition number 2050255.

3.4. General Procedure for the Synthesis of Intermediate B

Intermediate B was synthesized, as reported previously [24]. A mixture of 4-substituted mandelic acid (0.1 mol), 98% sulfuric acid (0.05 mol), and methanol (50 mL) was stirred at 80 °C for 3 h, and the reaction was monitored by TLC. Then, the solvent was concentrated under reduced pressure to obtain B, which was used in the next reaction without further purification.

3.5. General Synthesis Procedure for Intermediates C and D

Intermediate B (0.1 mol) and 80% hydrazine hydrate (0.2 mol) were dissolved in methanol (20 mL) and reacted at 100 °C for 30 min. Then, the solvent was concentrated in vacuo to obtain C. To a solution of KOH (0.15 mol) in 20 mL ethanol, C (0.1 mol) was added, and CS2 (0.2 mol) was slowly added dropwise into the solution, reacted at r.t. for 12 h and then reacted at 80 °C for 10 h. The solution was concentrated in vacuo. The pH value was adjusted to 3 to 4 with 2 M hydrochloric acid solution, and the mixture was extracted with ethyl acetate (50 mL × 3) and dried with anhydrous sodium sulfate. The ethyl acetate was removed under reduced pressure to obtain D, which was used in subsequent reactions without further purification.

3.6. General Synthesis Procedure for Target Compounds E1–E28

To a solution of D (4.0 mmol) in CH3CN/H2O (5.0 mL/5.0 mL), K2CO3 (8.0 mmol) and different benzyl halides (4.0 mmol) were added and reacted at r.t. for 24 h and then concentrated in vacuo. The residue was purified by column chromatography on silica gel (petroleum ether/ethyl acetate = 20/1~10/1) to obtain the title compounds E1–E28, and the physical and spectral data are provided in the Supporting Information Figures S1–S28.

3.7. In Vitro Antifungal Activity

The fungicidal activities of E1–E28 were tested in vitro against seven plant pathogenic fungi (G. saubinetii, V. dahlia, S. sclerotiorum, F. oxysporum, F. proliferatum, T. cucumeris, and P. capsici) using a mycelial growth inhibition method [25,26]. The preliminary activity screening concentration of the title compounds was 100 mg/L. The mycelial dishes of fungi that were used for testing were cut from the PDA medium cultivated at 25 ± 1 °C and were approximately 4 mm in diameter; the disks were inoculated in the middle of a PDA plate with a germ-free inoculation needle and then incubated for 3 to 5 days at the same temperature. DMSO (1%) in sterile distilled water served as a blank control (CK), whereas the commercialized fungicides mandipropamid and hymexazol served as the positive controls. Each treatment was conducted in triplicate. When the mycelia of the blank control grew to 6 cm, the diameters of the mycelia treated with the title compounds were recorded. Inhibitory effects on these fungi were calculated using the formula I (%) = [(C − T)/(C − 0.4)] × 100, where C represents the diameter of fungal growth of the blank control, T represents the diameter of the fungi with the treated compound, and I represents the inhibition rate. Standard deviation (SD) values were calculated based on the inhibition data of three repetitions for each test compound. Based on the in vitro antifungal activity results, the median effective concentrations (EC50) values of the highly active compounds were further determined according to the method described above. A series of activity screening concentrations of the title compounds and positive control consisting of 100, 50, 25, 12.5 or 6.25 mg/L were prepared. EC50 values were calculated by linear regression analysis with SPSS software 20.0. The regression equations of the title compounds are provided in Tables S2–S6 in the Supporting Information.

3.8. Morphological Observation of G. saubinetii by Scanning Electron Microscopy

To observe the effects of the high-antifungal-activity title compounds on the morphology of fungi, the morphology of the hyphae after treatment with the compound E13 was observed by SEM on the basis of previous methods [27,28,29]. For the SEM experiments, six fungal cakes (4.0 mm) of the G. saubinetii were taken and incubated in PDB (potato dextrose broth) medium at 28 °C and 180 rpm for 24 h, and then compound E13 was added to each group at different concentrations (0, 2 eq., 4 eq., and 8 eq. EC50), and incubated under the same conditions for 24 h. The mycelia were centrifuged (6000 rpm, 5 min, 4 °C) and washed with PBS buffer (pH 7.2) three times. Then, 2.5% glutaraldehyde was added, and the samples were placed in a refrigerator at 4 °C overnight and dehydrated with gradient ethanol (30%, 50%, 70%, 90%, and 100%) and t-butanol for 15 min. The dehydrated mycelia were dried in a vacuum and sprayed with gold. The mycelia were observed and photographed on a Nova Nano SEM scanning electron microscopy.

3.9. Morphological Observation of G. saubinetii by Fluorescence Microscope

According to previously reported methods [30,31], G. saubinetii hyphae were cultured in potato dextrose broth (PDB) medium at 28 °C and 180 rpm for 24 h and then treated with 0, 2, and 4 eq. EC50 of compound E13 for 24 h. The PDB medium was removed by centrifuging at 4 °C and 6000 rpm for 5 min, and the hyphae were stained with 10 μL of propidium iodide (PI) solution (20 mg/L). The hyphae were incubated at 37 °C for 15 min in the dark and then washed with PBS three times. A coverslip was placed on the hyphae, and the samples were observed and photographed using an Olympus-BX53F fluorescence microscopy.

3.10. Determination of Cytoplasmic Content Leakage

The leakage of cytoplasmic contents from G. saubinetii mycelia treated with E13 was measured according to the methods described previously with minor modifications [32,33]. Six cakes (4.0 mm) of G. saubinetii fungus were placed in 100 mL of PDB at 28 °C for 3 days at 180 rpm. The hyphae were harvested and washed three times with sterile distilled water. The mycelia (4.0 g) were suspended in 20 mL of distilled water containing compound E13 at various concentrations (0, 2 eq., and 4 eq. EC50) and incubated on a rotary shaker at 28 °C for 8 h. The absorbance values of the supernatant at 260 nm and 280 nm were determined at 0 h, 2 h, 4 h, 6 h, and 8 h, respectively. Each experiment was conducted in triplicate.

3.11. Statistical Analysis

Each experiment was performed in triplicate. The results are expressed as the means ± SD. The EC50 values were evaluated with the regression equation and r value. All the data in the same group were evaluated by the Q-test. Differences between groups were compared by one-way analysis of variance (ANOVA; Duncan’s multiple range test) with p < 0.05. Statistical tests were performed using the SPSS software package (version 20.0, IBM).

4. Conclusions

A series of 4-substituted mandelic acid derivatives containing a 1,3,4-oxadiazole moiety were designed and synthesized. In vitro bioassay results revealed that some title compounds exhibited excellent activity against seven kinds of pathogenic fungi. Among them, the EC50 values of E13 against G. saubinetii, E6 against V. dahlia, and E18 against S. sclerotiorum were 20.4, 12.7, and 8.0 mg/L, respectively, which were highly superior to that of the commercialized fungicide mandipropamid. A morphological study of G. saubinetii with FM and SEM indicated that E13 broke the surface of the hyphae and destroyed cell membrane integrity with the increased concentration, thereby inhibiting fungal reproduction. Further cytoplasmic content leakage determination results showed a dramatic increase of the nucleic acid and protein concentrations in mycelia with E13 treatment, which also indicated that the title compound E13 could destroy the cell membrane integrity and affect the growth of fungi. Further mechanistic research is planned for future completion.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms24108898/s1.

Author Contributions

B.C. conducted the experiments and wrote the article. D.S. participated in the design and synthesis of compounds. H.S. and K.C. tested the biological activity of the compounds. Z.W. and H.C. guided and conceived the experiments. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Science and Technology Fund of Guizhou Province (ZK2022457), Guizhou Province Department of Education fund (KY2020254), Guizhou University of Traditional Chinese Medicine Doctoral Fund ([2019]118), Guizhou Provincial Science and Technology Projects (Guizhou Scientific Foundation-ZK [2021] General 524), and the National Natural Science Foundation of China (No. 32160655).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data generated in this study is presented in the current manuscript. No new datasets were generated. Data is available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wen, L.; Jian, W.L.; Shang, J.B.; He, D.H. Synthesis and antifungal activities of novel thiophene-based stilbene derivatives bearing an 1,3,4-oxadiazole unit. Pest Manag. Sci. 2018, 75, 1123–1130. [Google Scholar] [CrossRef] [PubMed]
  2. Ma, Y.H.; Yang, L.R.; Liu, X.X.; Yang, J.; Sun, X.L. Development of celecoxib-derived antifungals for crop protection. Bioorg. Chem. 2020, 97, 103670–103675. [Google Scholar] [CrossRef] [PubMed]
  3. Liu, D.; Luo, L.; Wang, Z.X.; Ma, X.Y.; Gan, X.H. Design, Synthesis and Antifungal/Nematicidal Activity of Novel 1,2,4-Oxadiazole Derivatives Containing Amide Fragments. Int. J. Mol. Sci. 2022, 23, 1596. [Google Scholar] [CrossRef]
  4. Wang, L.L.; Li, C.; Zhang, Y.Y.; Qiao, C.H.; Ye, Y.H. Synthesis and biological evaluation of benzofuroxan derivatives as fungicides against phytopathogenic fungi. J. Agric. Food Chem. 2013, 61, 8632–8640. [Google Scholar] [CrossRef] [PubMed]
  5. Price, C.; Parker, J.; Warrilow, A.; Kelly, D.; Kelly, S. Azole fungicides–understanding resistance mechanisms in agricultural fungal pathogens. Pest Manag. Sci. 2015, 71, 1054–1058. [Google Scholar] [CrossRef] [PubMed]
  6. Yu, X.Q.; Zhu, X.Y.; Zhou, Y.; Li, Q.L.; Hu, Z.; Li, T.; Tao, J.; Dou, M.L.; Zhang, M.; Shao, Y.; et al. Discovery of N-aryl-pyridine-4-ones as novel potential agrochemical fungicides and bactericides. J. Agric. Food Chem. 2019, 67, 13904–13913. [Google Scholar] [CrossRef]
  7. Zhu, J.K.; Gao, J.M.; Yang, C.J.; Shang, X.F.; Zhao, Z.M.; Lawoe, R.K.; Zhou, R.; Sun, Y.; Yin, X.D.; Liu, Y.Q. Design, Synthesis, and antifungal evaluation of neocryptolepine derivatives against phytopathogenic fungi. J. Agric. Food Chem. 2020, 68, 2306–2315. [Google Scholar] [CrossRef]
  8. Yang, J.L.; Guan, A.Y.; Li, Z.N.; Zhang, P.F.; Liu, C.L. Design, synthesis, and structure−activity relationship of novel piropyrimidinamines as fungicides against Pseudoperonospora cubensis. J. Agric. Food Chem. 2020, 68, 6485–6492. [Google Scholar] [CrossRef]
  9. Ding, J.W.; Zhang, M.; Dai, H.X.; Lin, C.M. Enantioseparation of chiral mandelic acid derivatives by supercritical fluid chromatography. Chirality 2018, 30, 1245–1256. [Google Scholar] [CrossRef]
  10. Lukito, B.R.; Sekar, B.S.; Wu, S.; Li, Z. Whole cell-based cascade biotransformation for the production of (S)-mandelic acid from styrene, L-phenylalanine, glucose, or glycerol. Adv. Synth. Catal. 2019, 361, 3560. [Google Scholar] [CrossRef]
  11. Sajini, T.; John, S.; Mathew, B. Rational design and tailoring of imprinted polymeric enantioselective sensor layered on multiwalled carbon nanotubes for the chiral recognition of D-mandelic acid. Polym. Chem. 2019, 10, 5364–5384. [Google Scholar] [CrossRef]
  12. Keinath, A.P. Utility of a cucumber plant bioassay to assess fungicide efficacy against Pseudoperonospora cubensis. Plant Dis. 2016, 100, 490–499. [Google Scholar] [CrossRef] [PubMed]
  13. Qu, T.; Shao, Y.Y.; Csinos, A.S.; Ji, P.S. Sensitivity of phytophthora nicotianae from tobacco to fluopicolide, mandipropamid, and oxathiapiprolin. Plant Dis. 2016, 100, 2119–2125. [Google Scholar] [CrossRef] [PubMed]
  14. Wang, P.Y.; Zhou, L.; Zhou, J.; Wu, Z.B.; Xue, W.; Song, B.A.; Yang, S. Synthesis and antibacterial activity of pyridinium-tailored 2,5-substituted-1,3,4-oxadiazole thioether/sulfoxide/sulfone derivatives. Bioorg. Med. Chem. Lett. 2016, 26, 1214–1217. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, B.; Liu, F.; Li, Q.; Xu, S.; Zhao, X.Z.; Xue, P.L.; Feng, X. Antifungal activity of zedoary turmeric oil against Phytophthora capsica through damaging cell membrane. Pestic. Biochem. Phys. 2019, 159, 59–67. [Google Scholar] [CrossRef]
  16. Xiang, J.; Liu, D.Y.; Chen, J.X.; Hu, D.Y.; Song, B.A. Design and synthesis of novel 1,3,4-oxadiazole sulfone compounds containing 3,4-dichloroisothiazolylamide moiety and evaluation of rice bacterial activity. Pestic. Biochem. Phys. 2020, 170, 104695. [Google Scholar] [CrossRef]
  17. Wu, Y.Y.; Shao, W.B.; Zhu, J.J.; Long, Z.Q.; Liu, L.W.; Wang, P.Y.; Li, Z.; Yang, S. Novel 1,3,4-oxadiazole-2-carbohydrazides as prospective agricultural antifungal agents potentially targeting succinate dehydrogenase. J. Agric. Food Chem. 2019, 67, 13892–13903. [Google Scholar] [CrossRef]
  18. Gan, X.H.; Hu, D.Y.; Li, P.; Wu, J.; Chen, X.W.; Xue, W.; Song, B.A. Design, synthesis, antiviral activity and three-dimensional quantitative structure–activity relationship study of novel 1,4-pentadien-3-one derivatives containing the 1,3,4-oxadiazole moiety. Pest Manag. Sci. 2015, 72, 534–543. [Google Scholar] [CrossRef]
  19. Gan, X.H.; Hu, D.Y.; Chen, Z.; Wang, Y.J.; Song, B.A. Synthesis and antiviral evaluation of novel 1,3,4-oxadiazole/thiadiazole-chalcone conjugate. Bioorg. Med. Chem. Lett. 2017, 27, 4298–4301. [Google Scholar] [CrossRef]
  20. Yang, G.Q.; Zheng, H.L.; Shao, W.B.; Liu, L.W.; Wu, Z.B. Study of the in vivo antiviral activity against TMV treated with novel 1-(t-butyl)-5-amino-4-pyrazole derivatives containing a 1,3,4-oxadiazole sulfide moiety. Pestic. Biochem. Phys. 2020, 171, 104740. [Google Scholar] [CrossRef]
  21. Chen, J.X.; Wei, C.Q.; Wu, S.K.; Luo, Y.Q.; Wu, R.; Hu, D.Y.; Song, B.A. Novel 1,3,4-oxadiazole thioether derivatives containing flexible-chain moiety: Design, synthesis, nematocidal activities, and pesticide-likeness analysis. Bioorg. Med. Chem. Lett. 2020, 30, 127028. [Google Scholar] [CrossRef]
  22. Puig, M.; Moragrega, C.; Ruz, L.; Calderón, C.E.; Cazorla, F.M.; Montesinos, E.; Llorente, I. Interaction of antifungal peptide BP15 with Stemphylium vesicarium, the causal agent of brown spot of pear. Fungal Biol. 2016, 120, 61–71. [Google Scholar] [CrossRef] [PubMed]
  23. Yin, X.D.; Ma, K.Y.; Wang, Y.T.; Sun, Y.; Shang, X.F.; Zhao, Z.M.; Wang, R.Y.; Chen, Y.J.; Zhu, J.K.; Liu, Y.Q. Design, synthesis, and antifungal evaluation of 8-hydroxyquinoline metal complexes against phytopathogenic fungi. J. Agric. Food Chem. 2020, 68, 11096–11104. [Google Scholar] [CrossRef] [PubMed]
  24. Hamdani, S.S.; Khan, B.A.; Ahmed, M.N.; Hameed, S.; Akhter, K.; Ayub, K.; Mahmood, T. Synthesis, crystal structures, computational studies and α-amylase inhibition of three novel 1,3,4-oxadiazole derivatives. J. Mol. Struct. 2019, 1200, 127085. [Google Scholar] [CrossRef]
  25. Zhang, M.; Dai, Z.C.; Qian, S.S.; Liu, J.Y.; Xiao, Y.; Lu, A.M.; Zhu, H.L.; Wang, J.X.; Ye, Y.H. Design, synthesis, antifungal, and antioxidant activities of (E)-6-((2-Phenyl- hydrazono) methyl) quinoxaline derivatives. J. Agric. Food Chem. 2014, 62, 9637–9643. [Google Scholar] [CrossRef] [PubMed]
  26. Shi, J.; Luo, N.; Ding, M.H.; Bao, X.P. Synthesis, in vitro antibacterial and antifungal evaluation of novel 1,3,4-oxadiazole thioether derivatives bearing the 6-fluoroquinazolinylpiperidinyl moiety. Chin. Chem. Lett. 2020, 31, 434–438. [Google Scholar] [CrossRef]
  27. Cai, R.; Hu, M.M.; Zhang, Y.J.; Niu, C.; Yue, T.L.; Yuan, Y.H.; Wang, Z.L. Antifungal activity and mechanism of citral, limonene and eugenol against Zygosaccharomyces rouxii. LWT Food Sci. Technol. 2019, 106, 50–56. [Google Scholar] [CrossRef]
  28. Wang, M.W.; Zhu, H.H.; Wang, P.Y.; Zeng, D.; Wu, Y.Y.; Liu, L.W.; Wu, Z.B.; Li, Z.; Yang, S. Synthesis of thiazolium-labeled 1,3,4-oxadiazole thioethers as prospective antimicrobials: In vitro and in vivo bioactivity and mechanism of action. J. Agric. Food Chem. 2019, 67, 12696–12708. [Google Scholar] [CrossRef]
  29. Zhao, Y.T.; Yang, N.; Deng, Y.M.; Tao, K.; Jin, H.; Hou, T.P. Mechanism of action of novel pyrazole carboxamide containing a diarylamine scaffold against Rhizoctonia solani. J. Agric. Food Chem. 2020, 68, 11068–11076. [Google Scholar] [CrossRef]
  30. Zhang, Z.J.; Jiang, Z.Y.; Zhu, Q.; Zhong, G.H. Discovery of β-carboline oxadiazole derivatives as fungicidal agents against rice sheath blight. J. Agric. Food Chem. 2018, 66, 9598–9607. [Google Scholar] [CrossRef]
  31. Yang, Q.; Wang, J.; Zhang, P.; Xie, S.N.; Yuan, X.L.; Hou, X.D.; Yan, N.; Fang, Y.D.; Du, Y.M. In vitro and in vivo antifungal activity and preliminary mechanism of cembratrien-diols against Botrytis cinerea. Ind. Crop. Prod. 2020, 154, 112745–112755. [Google Scholar] [CrossRef]
  32. Ma, D.Y.; Ji, D.C.; Zhang, Z.Q.; Li, B.Q.; Qin, G.Z.; Xu, Y.; Chen, T.; Tian, S.P. Efficacy of rapamycin in modulating autophagic activity of Botrytis cinerea for controlling gray mold. Postharvest Biol. Tec. 2019, 150, 158–165. [Google Scholar] [CrossRef]
  33. Wang, Y.; Liu, X.Y.; Chen, T.; Xu, Y.; Tian, S.P. Antifungal effects of hinokitiol on development of Botrytis cinerea in vitro and in vivo. Postharvest Biol. Tec. 2020, 159, 111038. [Google Scholar] [CrossRef]
Ijms 24 08898 g001 550
Figure 1. Bioactive structures containing a “1,3,4-oxadiazole” moiety. Compound 1 is from Wang et al., 2016 [14]. Compound 2 is from Wang et al., 2019 [15]. Compound 3 is from Xiang et al., 2020 [16]. Compound 4 is from Wu et al., 2019 [17]. Compound 5 is from Gan et al., 2015 [18] and Gan et al. [19], 2017. Compound 6 is from Yang et al., 2020 [20]. Compound 7 is from Chen et al., 2020 [21].
Figure 1. Bioactive structures containing a “1,3,4-oxadiazole” moiety. Compound 1 is from Wang et al., 2016 [14]. Compound 2 is from Wang et al., 2019 [15]. Compound 3 is from Xiang et al., 2020 [16]. Compound 4 is from Wu et al., 2019 [17]. Compound 5 is from Gan et al., 2015 [18] and Gan et al. [19], 2017. Compound 6 is from Yang et al., 2020 [20]. Compound 7 is from Chen et al., 2020 [21].
Ijms 24 08898 g001
Ijms 24 08898 g002 550
Figure 2. Design and optimization of the title compounds.
Figure 2. Design and optimization of the title compounds.
Ijms 24 08898 g002
Ijms 24 08898 g003 550
Figure 3. Synthetic route of the title compounds.
Figure 3. Synthetic route of the title compounds.
Ijms 24 08898 g003
Ijms 24 08898 g004 550
Figure 4. Crystal structure of title compound E9.
Figure 4. Crystal structure of title compound E9.
Ijms 24 08898 g004
Ijms 24 08898 g005 550
Figure 5. Morphological study of G. saubinetii treated with E13 at different dosages in PDB by SEM. (A) 0 mg/L (CK); (B) 2 eq. EC50; (C) 4 eq. EC50; (D) 8 eq. EC50.
Figure 5. Morphological study of G. saubinetii treated with E13 at different dosages in PDB by SEM. (A) 0 mg/L (CK); (B) 2 eq. EC50; (C) 4 eq. EC50; (D) 8 eq. EC50.
Ijms 24 08898 g005
Ijms 24 08898 g006 550
Figure 6. Morphology of G. saubinetii treated with E13 at different dosages under optical microscopy and fluorescence microscopy. (A–C: bright field; D–F: fluorescence field. A,D 0 mg/L (CK); B,E: 2 eq. EC50; C,F: 4 eq. EC50).
Figure 6. Morphology of G. saubinetii treated with E13 at different dosages under optical microscopy and fluorescence microscopy. (A–C: bright field; D–F: fluorescence field. A,D 0 mg/L (CK); B,E: 2 eq. EC50; C,F: 4 eq. EC50).
Ijms 24 08898 g006
Ijms 24 08898 g007 550
Figure 7. Leakage of cytoplasmic contents of G. saubinetii mycelia with E13 treatment. (A) nucleic acid concentration; (B) protein concentration. a,b,c Different lowercase letters in a column indicate significant differences between mean values evaluated by Duncan’s multiple range test (p < 0.05).
Figure 7. Leakage of cytoplasmic contents of G. saubinetii mycelia with E13 treatment. (A) nucleic acid concentration; (B) protein concentration. a,b,c Different lowercase letters in a column indicate significant differences between mean values evaluated by Duncan’s multiple range test (p < 0.05).
Ijms 24 08898 g007
Table
Table 1. Inhibition effect of title compounds against seven pathogenic fungi at 100 mg/L a.
Table 1. Inhibition effect of title compounds against seven pathogenic fungi at 100 mg/L a.
Compound
No.		Inhibition Rate ± SD (%)
GSVDSSFOFPTCPC
E169.9 ± 2.073.8 ± 3.088.8 ± 2.359.1 ± 0.957.1 ± 0.565.8 ± 0.829.2 ± 1.3
E269.6 ± 1.169.4 ± 0.971.8 ± 3.910.9 ± 2.730.3 ± 0.845.8 ± 1.739.8 ± 0.5
E3016.1 ± 0.511.3 ± 0.5011.2 ± 0.548.3 ± 2.211.1 ± 1.8
E427.5 ± 2.022.1 ± 0.521.7 ± 4.0015.6 ± 0.825.3 ± 2.423.7 ± 0.9
E524.5 ± 0.022.4 ± 1.111.9 ± 1.954.2 ± 0.558.2 ± 0.884.9 ± 0.536.6 ± 3.3
E664.1 ± 0.693.8 ± 1.949.4 ± 0.59.4 ± 4.133.1 ± 0.567.5 ± 1.732.8 ± 2.2
E775.3 ± 2.980.3 ± 2.872.4 ± 1.735.8 ± 0.556.6 ± 0.881.4 ± 1.362.3 ±0.9
E864.1 ± 1.050.6 ± 0.583.1 ± 2.611.2 ± 0.528.1 ± 1.024.7 ± 1.717.3 ± 0.5
E959.8 ± 0.583.0 ± 1.992.8 ± 0.58.2 ± 0.938.9 ± 1.319.7 ± 2.626.9 ± 1.3
E1078.5 ± 0.391.8 ± 2.287.5 ± 0.069.4 ± 1.468.3 ± 0.581.1 ± 1.153.8 ± 1.0
E1165.7 ± 0.075.2 ± 0.568.8 ± 2.78.8 ± 2.321.0 ± 3.141.4 ± 5.45.0 ± 0.5
E1248.7 ± 0.665.2 ± 0.554.5 ± 1.833.3 ± 1.438.3 ± 0.528.1 ± 1.346.5 ± 0.9
E1378.3 ± 0.910092.5 ± 0.870.3 ± 0.569.7 ± 0.887.5 ± 0.076.3 ± 1.5
E1480.2 ± 0.995.9 ± 1.471.9 ± 3.868.8 ± 1.169.1 ± 1.366.9 ± 0.570.2 ± 1.8
E1537.9 ± 0.623.6 ± 0.034.2 ± 1.427.3 ± 1.649.5 ± 2.460.8 ± 1.761.1 ± 2.0
E1642.3 ± 1.339.3 ± 1.024.9 ± 1.127.0 ± 1.031.8 ± 0.849.2 ± 0.735.1 ± 0.9
E1769.5 ± 2.283.3 ± 2.289.7 ± 0.510.0 ± 1.812.3 ± 0.718.1 ± 0.558.2 ± 1.0
E1873.3 ± 1.781.3 ± 1.869.0 ± 0.9024.3 ± 2.548.1 ± 0.537.7 ± 1.5
E1966.0 ± 2.567.9 ± 0.069.7 ± 0.552.4 ± 1.039.3 ± 0.957.3 ± 0.848.8 ± 0.5
E2076.0 ± 1.994.4 ± 0.080.5 ± 0.569.0 ± 2.569.7 ± 1.765.9 ± 1.074.2 ± 0.9
E2165.1 ± 0.681.8 ± 1.977.3 ± 0.524.9 ± 2.660.9 ± 0.561.2 ± 1.18.5 ± 1.0
E2271.6 ± 1.164.2 ± 0.667.9 ± 0.5--------
E2372.2 ± 1.080.6 ± 0.652.5 ± 0.5--------
E2474.1 ± 1.081.6 ± 0.665.1 ± 2.8--------
E2571.9 ± 0.678.2 ± 1.657.1 ± 1.1--------
E2673.8 ± 0.680.9 ± 1.061.7 ± 1.4--------
E2774.4 ± 2.068.6 ± 1.574.1 ± 0.9--------
E2876.0 ± 1.074.6 ± 0.667.9 ± 0.5--------
MP19.1 ± 0.427.2 ± 0.914.0 ± 0.526.5 ± 0.927.5 ± 1.123.6 ± 1.925.2 ± 1.0
HY----------79.3 ± 1.669.6 ± 0.5
a Values are means ± SD of three replicates. “--” not test. GS: Gibberella saubinetii (Durieu and Mont.) Sacc.; VD: Verticillium dahliae Kleb.; SS: Sclerotinia sclerotiorum (Lib.) de Bary; FO: Fusarium oxysporum f. sp. Cucumerinum; FP: Fusarium proliferatum (Matsush.) Nirenberg ex Gerlach and Nirenberg; TC: Thanatephorus cucumeris (A.B. Frank) Donk; PC: Phytophthora capsici Leonian; MP: mandipropamid; HY: hymexazol. MP and HY were pure compounds.
Table
Table 2. EC50 values of some title compounds against five kinds of pathogenic fungi a.
Table 2. EC50 values of some title compounds against five kinds of pathogenic fungi a.
Compound No.EC50 (mg/L)
GSVDSSTCPC
E147.4 ± 2.650.7 ± 2.823.0 ± 1.5----
E237.3 ± 1.437.2 ± 1.227.1 ± 1.5----
E5------18.5 ± 0.4--
E649.9 ± 0.412.7 ± 0.590.5 ± 3.5----
E730.6 ± 3.014.3 ± 0.140.1 ± 2.75.7 ± 0.2--
E879.1 ± 2.6>10013.8 ± 3.1----
E924.6 ± 0.729.0 ± 2.110.3 ± 1.0----
E1029.4 ± 0.637.2 ± 1.021.9 ± 0.436.3 ± 1.3--
E1320.4 ± 1.318.5 ± 1.233.5 ± 1.87.1 ± 0.142.9 ± 0.7
E1421.5 ± 1.023.1 ± 0.837.6 ± 1.9--49.3 ± 1.4
E1722.0 ± 1.516.1 ± 0.227.9 ± 0.2----
E1824.5 ± 0.915.8 ± 1.48.0 ± 0.3----
E1956.1 ± 0.965.7 ± 0.747.8 ± 1.7----
E2031.6 ± 0.629.6 ± 2.339.1 ± 1.1--50.9 ± 1.4
E2127.3 ± 2.013.4 ± 0.636.3 ± 0.337.6 ± 1.0--
E2251.1 ± 0.261.3 ± 1.648.5 ± 0.4----
E2332.5 ± 0.932.3 ± 0.481.4 ± 2.1----
E2430.8 ± 1.538.5 ± 1.051.6 ± 5.4----
E2531.3 ± 1.533.7 ± 3.575.2 ± 3.4----
E2632.7 ± 1.130.4 ± 1.354.0 ± 1.8----
E2725.2 ± 1.043.0 ± 1.637.2 ± 0.8----
E2824.2 ± 0.426.9 ± 0.247.9 ± 0.2----
MP>100>100>100----
HY------13.8 ± 1.517.9 ± 1.3
a Values are means ± SD of three replicates. “--” not test.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chen, B.; Song, D.; Shi, H.; Chen, K.; Wu, Z.; Chai, H. Design, Synthesis, In Vitro Antifungal Activity and Mechanism Study of the Novel 4-Substituted Mandelic Acid Derivatives. Int. J. Mol. Sci. 2023, 24, 8898. https://doi.org/10.3390/ijms24108898

AMA Style

Chen B, Song D, Shi H, Chen K, Wu Z, Chai H. Design, Synthesis, In Vitro Antifungal Activity and Mechanism Study of the Novel 4-Substituted Mandelic Acid Derivatives. International Journal of Molecular Sciences. 2023; 24(10):8898. https://doi.org/10.3390/ijms24108898

Chicago/Turabian Style

Chen, Biao, Dandan Song, Huabin Shi, Kuai Chen, Zhibing Wu, and Huifang Chai. 2023. "Design, Synthesis, In Vitro Antifungal Activity and Mechanism Study of the Novel 4-Substituted Mandelic Acid Derivatives" International Journal of Molecular Sciences 24, no. 10: 8898. https://doi.org/10.3390/ijms24108898

APA Style

Chen, B., Song, D., Shi, H., Chen, K., Wu, Z., & Chai, H. (2023). Design, Synthesis, In Vitro Antifungal Activity and Mechanism Study of the Novel 4-Substituted Mandelic Acid Derivatives. International Journal of Molecular Sciences, 24(10), 8898. https://doi.org/10.3390/ijms24108898

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop